BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20087880)

  • 1. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
    Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
    J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ
    J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis.
    Patek CE; Arends MJ; Wallace WA; Luo F; Hagan S; Brownstein DG; Rose L; Devenney PS; Walker M; Plowman SJ; Berry RL; Kolch W; Sansom OJ; Harrison DJ; Hooper ML
    Exp Cell Res; 2008 Mar; 314(5):1105-14. PubMed ID: 18062963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.
    Patek CE; Arends MJ; Rose L; Luo F; Walker M; Devenney PS; Berry RL; Lawrence NJ; Ridgway RA; Sansom OJ; Hooper ML
    BMC Gastroenterol; 2008 Jun; 8():24. PubMed ID: 18554389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild-type K-ras has a tumour suppressor effect on carcinogen-induced murine colorectal adenoma formation.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Dong G; Zhang W; Ibrahim AE; Arends MJ
    Int J Exp Pathol; 2014 Feb; 95(1):8-15. PubMed ID: 24354449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice.
    Plowman SJ; Arends MJ; Brownstein DG; Luo F; Devenney PS; Rose L; Ritchie AM; Berry RL; Harrison DJ; Hooper ML; Patek CE
    Exp Cell Res; 2006 Jan; 312(1):16-26. PubMed ID: 16271715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer.
    Plowman SJ; Berry RL; Bader SA; Luo F; Arends MJ; Harrison DJ; Hooper ML; Patek CE
    J Exp Clin Cancer Res; 2006 Jun; 25(2):259-67. PubMed ID: 16918139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Arends MJ
    Oncol Rep; 2011 Jul; 26(1):125-33. PubMed ID: 21573497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
    Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
    Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
    Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
    Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary supplementation of lutein reduces colon carcinogenesis in DMH-treated rats by modulating K-ras, PKB, and β-catenin proteins.
    Reynoso-Camacho R; González-Jasso E; Ferriz-Martínez R; Villalón-Corona B; Loarca-Piña GF; Salgado LM; Ramos-Gomez M
    Nutr Cancer; 2011; 63(1):39-45. PubMed ID: 21128180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis.
    Boparai KS; Dekker E; Van Eeden S; Polak MM; Bartelsman JF; Mathus-Vliegen EM; Keller JJ; van Noesel CJ
    Gastroenterology; 2008 Dec; 135(6):2014-8. PubMed ID: 19013464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
    Kim H; Yang XL; Rosada C; Hamilton SR; August JT
    Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis.
    Ward RL; Todd AV; Santiago F; O'Connor T; Hawkins NJ
    Cancer; 1997 Mar; 79(6):1106-13. PubMed ID: 9070487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomas.
    James RM; Arends MJ; Plowman SJ; Brooks DG; Miles CG; West JD; Patek CE
    Mol Cancer Res; 2003 Sep; 1(11):820-5. PubMed ID: 14517344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable.
    Plowman SJ; Williamson DJ; O'Sullivan MJ; Doig J; Ritchie AM; Harrison DJ; Melton DW; Arends MJ; Hooper ML; Patek CE
    Mol Cell Biol; 2003 Dec; 23(24):9245-50. PubMed ID: 14645534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.